Clinical Trial Update: Cohort Study in Senegal Comparing Artesunate + Amiodaquine in the Treatment of Repeated Uncomplicated Plasmodium Falciparum Malaria Attacks [Phase 4]

View source ↗

Summary

Phase 4 trial in Senegal evaluating artesunate plus amodiaquine for repeated uncomplicated Plasmodium falciparum malaria attacks; study completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Plasmodium Falciparum Malaria

Drugs mentioned

• Amodiaquine (Amodiaquine)
• Artesunate (artesunate)

Snippet

Sponsor: Sanofi | Conditions: Malaria | Phase 4 | Status: COMPLETED